[go: up one dir, main page]

GB9908807D0 - Synthetic signalling molecules - Google Patents

Synthetic signalling molecules

Info

Publication number
GB9908807D0
GB9908807D0 GBGB9908807.2A GB9908807A GB9908807D0 GB 9908807 D0 GB9908807 D0 GB 9908807D0 GB 9908807 A GB9908807 A GB 9908807A GB 9908807 D0 GB9908807 D0 GB 9908807D0
Authority
GB
United Kingdom
Prior art keywords
signalling molecules
synthetic signalling
synthetic
molecules
signalling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9908807.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech R&D Ltd
Original Assignee
Celltech Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Therapeutics Ltd filed Critical Celltech Therapeutics Ltd
Priority to GBGB9908807.2A priority Critical patent/GB9908807D0/en
Publication of GB9908807D0 publication Critical patent/GB9908807D0/en
Priority to JP2000612451A priority patent/JP2002541844A/en
Priority to PCT/GB2000/001456 priority patent/WO2000063372A1/en
Priority to EP00927406A priority patent/EP1173569A1/en
Priority to AU45813/00A priority patent/AU4581300A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
GBGB9908807.2A 1999-04-16 1999-04-16 Synthetic signalling molecules Ceased GB9908807D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9908807.2A GB9908807D0 (en) 1999-04-16 1999-04-16 Synthetic signalling molecules
JP2000612451A JP2002541844A (en) 1999-04-16 2000-04-17 Synthetic signaling molecules
PCT/GB2000/001456 WO2000063372A1 (en) 1999-04-16 2000-04-17 Synthetic signalling molecules
EP00927406A EP1173569A1 (en) 1999-04-16 2000-04-17 Synthetic signalling molecules
AU45813/00A AU4581300A (en) 1999-04-16 2000-04-17 Synthetic signalling molecules

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908807.2A GB9908807D0 (en) 1999-04-16 1999-04-16 Synthetic signalling molecules

Publications (1)

Publication Number Publication Date
GB9908807D0 true GB9908807D0 (en) 1999-06-09

Family

ID=10851730

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9908807.2A Ceased GB9908807D0 (en) 1999-04-16 1999-04-16 Synthetic signalling molecules

Country Status (5)

Country Link
EP (1) EP1173569A1 (en)
JP (1) JP2002541844A (en)
AU (1) AU4581300A (en)
GB (1) GB9908807D0 (en)
WO (1) WO2000063372A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4418900A (en) 1999-04-16 2000-11-02 Celltech Therapeutics Limited Synthetic transmembrane components
GB9925848D0 (en) * 1999-11-01 1999-12-29 Celltech Therapeutics Ltd Biological products
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
GB0523954D0 (en) * 2005-11-24 2006-01-04 Ucb Celltech Bioassays
GB0614780D0 (en) 2006-07-25 2006-09-06 Ucb Sa Biological products
WO2015075470A1 (en) 2013-11-21 2015-05-28 Ucl Business Plc Cell
HRP20240357T1 (en) 2014-12-24 2024-06-07 Autolus Limited Cell
GB201507111D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic acid construct
GB201507119D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic Acid Construct
GB201507115D0 (en) 2015-04-27 2015-06-10 Ucl Business Plc Nucleic Acid Construct
GB201509413D0 (en) 2015-06-01 2015-07-15 Ucl Business Plc Fusion protein
GB201610512D0 (en) 2016-06-16 2016-08-03 Autolus Ltd Chimeric antigen receptor
CA3042613A1 (en) 2016-11-11 2018-05-17 Autolus Limited Chimeric antigen receptor
GB201707779D0 (en) 2017-05-15 2017-06-28 Autolus Ltd Cell
GB201903237D0 (en) 2019-03-08 2019-04-24 Autolus Ltd Method
CA3131839A1 (en) 2019-03-08 2020-09-17 Autolus Limited Compositions and methods comprising engineered chimeric antigen receptor and modulator of car
GB201910185D0 (en) 2019-07-16 2019-08-28 Autolus Ltd Method
US20220257757A1 (en) 2019-07-16 2022-08-18 Autolus Limited Method for preconditioning a subject who is about to receive a t-cell therapy
GB202006820D0 (en) 2020-05-07 2020-06-24 Autolus Ltd Cell
GB202007044D0 (en) 2020-05-13 2020-06-24 Autolus Ltd Method
GB202312009D0 (en) 2023-08-04 2023-09-20 Autolus Ltd Methods and cell compositions
KR20250043848A (en) 2023-09-22 2025-03-31 한국건설기술연구원 Multi-function movable ground station for remote controlling, power supplying, and data transmitting and receiving of measuring equipment, and measuring equipment managing system having the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6098194A (en) * 1993-01-29 1994-08-15 Ariad Pharmaceuticals, Inc. Analogs of receptor tyrosine activation motifs and therapeutic uses thereof
DK0871495T3 (en) * 1995-02-24 2005-10-17 Gen Hospital Corp Redirecting cellular immunity with receptor chimeras
GB9526131D0 (en) * 1995-12-21 1996-02-21 Celltech Therapeutics Ltd Recombinant chimeric receptors
GB9713473D0 (en) * 1997-06-25 1997-09-03 Celltech Therapeutics Ltd Biological products

Also Published As

Publication number Publication date
EP1173569A1 (en) 2002-01-23
JP2002541844A (en) 2002-12-10
WO2000063372A1 (en) 2000-10-26
AU4581300A (en) 2000-11-02

Similar Documents

Publication Publication Date Title
GB9908807D0 (en) Synthetic signalling molecules
AU5151100A (en) Extracellular signaling molecules
GB0118297D0 (en) Synthetic closure
GB9903584D0 (en) Modified calycins
GB9921703D0 (en) Edgings
GB9920774D0 (en) Polymer
GB0025317D0 (en) Vehicular haedlamp
GB0026677D0 (en) Signalling means
AU141528S (en) Counter
GB0013088D0 (en) Polymers
GB9907226D0 (en) Clip
GB9806945D0 (en) Signalling
GB0005139D0 (en) Signalling device
GB2339943B (en) Signalling system
GB2357798B (en) Plant-on dividing bar arrangement
GB9922281D0 (en) Polymorphism
GB2355280B (en) Clip
GB9912635D0 (en) Molecules
HUP0100269A3 (en) Signalling device
PL343455A1 (en) Plastic section
PL326800A1 (en) Signalling unit
GB9917687D0 (en) Synthetic aggregate
GB2351581B (en) The saudi pedagogy-ruler
GB9903523D0 (en) Signalling device
CA88407S (en) Clip

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)